DID YOU KNOW? DTIC has over 3.5 million final reports on DoD funded research, development, test, and evaluation activities available to our registered users. Click
HERE to register or log in.
Accession Number:
AD1036948
Title:
Cell Survival After Exposure to a Novel Endodontic Irrigant
Descriptive Note:
Technical Report
Corporate Author:
Uniformed Services University of the Health Sciences Kessler Air Force Base United States
Report Date:
2016-05-13
Pagination or Media Count:
11.0
Abstract:
Endocyn, a pH-neutral solution of hypochlorous acid and hypochlorite has been developed for use as an endodontic irrigant. The purpose of this study was to evaluate the effect of Endocyn on human periodontal ligament PDL fibroblasts and rat osteosarcoma cells UMR-106 and compare this with other commonly used endodontic irrigants. Methods To determine cytotoxicity, cultured PDL and commercially purchased UMR-106 cells were exposed to 1, 5, 10, 20, and 50 concentrations of Endocyn, 6 NaOCl, 17 EDTA, and 2 CHX for 10 minutes, 1 hour, and 24 hours by dissolving the irrigants into cell medium. Distilled water was used as the control. The cells were rendered fluorescent with Calcein AM to allow microscopic examination and determination of survival. Comparison of cell survival was performed by using an unpaired, 2-tailed Student t-test p0.05. Results Compared to distilled water, Endocyn showed no increased cytotoxicity to PDL cells at 10 minutes for all concentrations tested. The 20 and 50 concentrations of Endocyn resulted in a 10 decrease in PDL cells at 1 hour, while the 50 concentration resulted in a 20 decrease in PDL cells at 24 hours. At all concentrations, Endocyn showed no increased cytotoxicity to UMR-106 cells at 10 minutes and 24 hours and a slight increase 10 in cytotoxicity at 1 hour. All other experimental irrigants demonstrated significant cytotoxicity to both PDL and UMR-106 cells at all time intervals. Conclusion Endocyn was less cytotoxic to PDL and UMR-106 cells compared to other commonly used endodontic irrigants.
Distribution Statement:
APPROVED FOR PUBLIC RELEASE
